Psoriasis Peptides 2026 Update: Treatment Comparison
The table below compares peptide-based psoriasis treatments entering Phase 3 trials in 2026 against current standard-of-care biologics across efficacy, delivery, immunogenicity, and cost projections. IL-17A Peptide (PTX-401) Dire…